CLINICAL TRIALS PROFILE FOR EPHEDRINE HYDROCHLORIDE
✉ Email this page to a colleague
All Clinical Trials for Ephedrine Hydrochloride
| Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
|---|---|---|---|---|---|---|
| NCT00232817 ↗ | Anesthesia and Postoperative Pain | Completed | Columbia University | Phase 4 | 2003-07-01 | The purpose of this study is to compare post-operative pain after anesthesia with either isoflurane or propofol. Each group will be further randomized to recieve intranasal nicotine or placebo inorder to detect potetial pronociceptive action of isoflurane. The study is a randomized, prospective, double-blinded controlled trial. Eighty adult women undergoing uterine surgery will be recruited for this study. Enrollment in this study is limited to women, because our animal studies suggest that females have a greater hyperalgesic response to volatile anesthetics than do males. The patient will be given one of two standard anesthetics for their surgery: isoflurane or propofol. We are interested in these two anesthetics because we seek to see if there exists a difference in their effects on a patient's perception of pain, as has been shown to be the case in animal studies but has not yet been studied in humans. The primary outcome variable will be postoperative pain, as measured by a numerical analog pain score (VAS) at 5, 10, 15, 20, 25, 30, 35, 40, 45, 50, 55, 60, 120, and 1440 minutes postoperatively. Secondary outcome measures will include morphine utilization via PCA and hemodynamics variables including heart rate, systolic BP, and diastolic BP, all of which will be measured at the same time points as the VAS score. |
| NCT00267332 ↗ | Modafinil in Opioid Induced Sedation | Terminated | Sidney Kimmel Comprehensive Cancer Center | Phase 3 | 2006-01-01 | - The primary objective of this study is to evaluate the efficacy of modafinil in the treatment of opioid induced sedation as measured by the Epworth Sleepiness Scale (ESS). - The secondary objective is to estimate the frequency and severity of toxicity associated with Modafinil (400mg) in patients with opioid induced sedation. |
| NCT00267332 ↗ | Modafinil in Opioid Induced Sedation | Terminated | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | Phase 3 | 2006-01-01 | - The primary objective of this study is to evaluate the efficacy of modafinil in the treatment of opioid induced sedation as measured by the Epworth Sleepiness Scale (ESS). - The secondary objective is to estimate the frequency and severity of toxicity associated with Modafinil (400mg) in patients with opioid induced sedation. |
| NCT00377975 ↗ | "Pecos" B-adrenergic and PPAR-G Stimulation Upregulates Lipid Metabolism in Human Subcutaneous Fat | Completed | Pennington Biomedical Research Center | Phase 2 | 2003-01-01 | This study compares four treatments to see which one causes the most weight loss, fat loss, loss of abdominal fat and improvement in blood tests like cholesterol. The four treatments are: Placebo, Ephedrine plus caffeine, Pioglitazone, Combined pioglitazone and ephedrine plus caffeine |
| >Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for Ephedrine Hydrochloride
Condition Name
Clinical Trial Locations for Ephedrine Hydrochloride
Trials by Country
Clinical Trial Progress for Ephedrine Hydrochloride
Clinical Trial Phase
Clinical Trial Sponsors for Ephedrine Hydrochloride
Sponsor Name
